Study Detail: Alcon GAP

Trial Description Summary : This is a natural history study being done to assess the rate of progression of geographic atrophy by measuring the growth of the atrophic lesions.

Basic Trial Information

Inclusion Criteria

• Primary study eye must have a contiguous well-demarcated area of GA larger than 2.5 mm² and less than or equal to 12 mm² (>1 to ≤ 5 DA).
• Best corrected vision in study eye is 20/100 or better.
• Non-study eye must have either drusen ≥ 63 µm or Geographic Atrophy
• Other inclusion criteria per the study coordinator

   

  Exclusion Criteria

• Presence or history of CNV in either eye.
• Any ocular surgery within 90 days prior to the Baseline Visit.
• Current participation in other studies and previous or concomitant therapy to treat AMD.
• Other exclusion criteria per the study coordinator

  General Medical Exclusion Criteria

• Any systemic disease with a limited survival prognosis (e.g., cancer, severe/unstable cardiovascular disease).
• Known medical history of allergy or sensitivity to fluorescein dye that is clinically relevant.
• Evidence of significant uncontrolled concomitant diseases such as cardiovascular, neurological, pulmonary, renal, hepatic, endocrine or gastrointestinal disorders.
• Other general inclusion/exclusion criteria per the study coordinator

   

Trial Contact Information